Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-25

Clinical Trial Update: Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Ledipasvir/Sofosbuvir for Hepatitis B has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2021-08-25